Beeinflusst die Entscheidungskompetenz des Patienten die Auswahl der Immunmodulation?

Translated title of the contribution: Does the decision-making competence of the patient influence the choice of immunomodulation?

Anna Hedwig, Janina Hoffmann, Michael Jöbges, Christian Dettmers

Research output: Contribution to journalArticlepeer-review

Abstract

Shared decision-making (SDM) is widely recommended in chronic diseases
such as multiple sclerosis (MS) in order to assess and consider the
patient’s priorities adequately. SDM presupposes decision competence.
Decision competence can be tested by the Adult Decision Making Competence
(A-DMC) battery. Decision competence depends on an intact working
memory, which is often affected in patients with MS. Consequently, any
treatment-related education following an SDM approach has to consider
that decision competence can be hampered in patients with MS. At the
same time, risk preferences of the neurologist may influence selection of
the right immunomodulatory treatment. These possible impact factors
should be reflected to guarantee the optimal individualized medical care.
Keywords: shared decision-making, decision competence, decision rules,
risk perception, immunomodulatory treatment, multiple sclerosis
Translated title of the contributionDoes the decision-making competence of the patient influence the choice of immunomodulation?
Original languageGerman
Pages (from-to)63-66
Number of pages4
JournalNeurologie und Rehabilitation
Volume27
Issue number1
DOIs
Publication statusPublished - 31 Jan 2021

Cite this